Investigating the efficacy of oral propranolol in prevention of severe Retinopathy of Prematurity
Phase 3
Recruiting
- Conditions
- Retinopathy of prematurity.Retinopathy of prematurityH35.1
- Registration Number
- IRCT20101018004961N12
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
newborns with gestational age =34 weeks or birth weight =2000?g
with retinopathy of prematurity stage I or II
Exclusion Criteria
Infants with congenital anomalies
heart diseases except PDA
recurrent bradycardia
eye malformations
acute renal failure
IVH grade II and III,
acute sepsis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Stage of retinopathy. Timepoint: Day 28 after birth and then every 1 to 2 weeks until the retinal vascular are complete. Method of measurement: Ophthalmoscopic eye examination.
- Secondary Outcome Measures
Name Time Method